Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 329

1.

Prognostic significance of extent of ulceration in primary cutaneous melanoma.

Grande Sarpa H, Reinke K, Shaikh L, Leong SP, Miller JR 3rd, Sagebiel RW, Kashani-Sabet M.

Am J Surg Pathol. 2006 Nov;30(11):1396-400.

PMID:
17063079
2.

Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy.

Ranieri JM, Wagner JD, Azuaje R, Davidson D, Wenck S, Fyffe J, Coleman JJ 3rd.

Ann Surg Oncol. 2002 Dec;9(10):975-81.

PMID:
12464589
3.

Sentinel lymph node biopsy does not change melanoma-specific survival among patients with Breslow thickness greater than four millimeters.

Caracò C, Celentano E, Lastoria S, Botti G, Ascierto PA, Mozzillo N.

Ann Surg Oncol. 2004 Mar;11(3 Suppl):198S-202S.

PMID:
15023751
4.

Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.

Niakosari F, Kahn HJ, McCready D, Ghazarian D, Rotstein LE, Marks A, Kiss A, From L.

Arch Dermatol. 2008 Apr;144(4):462-7. doi: 10.1001/archderm.144.4.462.

PMID:
18427039
5.

High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.

van Akkooi AC, de Wilt JH, Verhoef C, Graveland WJ, van Geel AN, Kliffen M, Eggermont AM.

Eur J Cancer. 2006 Feb;42(3):372-80. Epub 2006 Jan 5.

PMID:
16403622
6.

Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.

Debarbieux S, Duru G, Dalle S, Béatrix O, Balme B, Thomas L.

Br J Dermatol. 2007 Jul;157(1):58-67. Epub 2007 May 14.

PMID:
17501957
7.

Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.

Koskivuo I, Talve L, Vihinen P, Mäki M, Vahlberg T, Suominen E.

Ann Surg Oncol. 2007 Dec;14(12):3566-74. Epub 2007 Oct 9.

PMID:
17924169
8.

Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.

Gannon CJ, Rousseau DL Jr, Ross MI, Johnson MM, Lee JE, Mansfield PF, Cormier JN, Prieto VG, Gershenwald JE.

Cancer. 2006 Dec 1;107(11):2647-52.

9.

Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.

Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS.

J Clin Oncol. 2007 Mar 1;25(7):869-75.

PMID:
17327608
10.

Significance of multiple lymphatic basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy.

McHugh JB, Su L, Griffith KA, Schwartz JL, Wong SL, Cimmino V, Chang AE, Johnson TM, Sabel MS.

Ann Surg Oncol. 2006 Sep;13(9):1216-23. Epub 2006 Sep 3.

PMID:
16952026
11.

Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.

Vitoux D, Mourah S, Kerob D, Verola O, Basset-Seguin N, Baccard M, Schartz N, Ollivaud L, Archimbaud A, Servant JM, Revol M, Toubert ME, Podgorniak MP, Plassa F, Porcher R, Lebbé C.

Arch Dermatol. 2009 Oct;145(10):1105-13. doi: 10.1001/archdermatol.2009.209.

PMID:
19841396
12.

The prognostic role of the sentinel lymph node in clinically node-negative patients with cutaneous melanoma: experience of the Genoa group.

Gipponi M, Solari N, Lionetto R, Di Somma C, Villa G, Schenone F, Queirolo P, Cafiero F.

Eur J Surg Oncol. 2005 Dec;31(10):1191-7.

PMID:
15894454
13.

Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.

Mandalà M, Imberti GL, Piazzalunga D, Belfiglio M, Labianca R, Barberis M, Marchesi L, Poletti P, Bonomi L, Novellino L, Di Biagio K, Milesi A, Guerra U, Tondini C.

Eur J Cancer. 2009 Sep;45(14):2537-45. doi: 10.1016/j.ejca.2009.05.034. Epub 2009 Jun 22.

PMID:
19553103
14.

Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.

Kruper LL, Spitz FR, Czerniecki BJ, Fraker DL, Blackwood-Chirchir A, Ming ME, Elder DE, Elenitsas R, Guerry D, Gimotty PA.

Cancer. 2006 Nov 15;107(10):2436-45.

15.

Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.

Scheri RP, Essner R, Turner RR, Ye X, Morton DL.

Ann Surg Oncol. 2007 Oct;14(10):2861-6. Epub 2007 Jul 18.

PMID:
17882497
16.

Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.

Petitt M, Allison A, Shimoni T, Uchida T, Raimer S, Kelly B.

J Am Acad Dermatol. 2009 Nov;61(5):819-28. doi: 10.1016/j.jaad.2009.04.026.

PMID:
19836642
17.

Long-term follow-up reveals that ulceration and sentinel lymph node status are the strongest predictors for survival in patients with primary cutaneous melanoma.

de Vries M, Speijers MJ, Bastiaannet E, Plukker JT, Brouwers AH, van Ginkel RJ, Suurmeijer AJ, Hoekstra HJ.

Eur J Surg Oncol. 2011 Aug;37(8):681-7. doi: 10.1016/j.ejso.2011.05.003. Epub 2011 Jun 1.

PMID:
21636244
18.

Sentinel lymph node biopsy in cutaneous melanoma: outcome after 5-years follow-up.

Cuchet E, Pinel N, Corcella D, Vuillez JP, Lebeau J, Moutet F, Colonna M, Leccia MT.

Eur J Dermatol. 2007 Sep-Oct;17(5):387-91. Epub 2007 Aug 2.

PMID:
17673381
19.

The new melanoma staging system.

Kim CJ, Reintgen DS, Balch CM; AJCC Melanoma Staging Committee.

Cancer Control. 2002 Jan-Feb;9(1):9-15. Review.

PMID:
11907461
20.

Factors predicting recurrence and survival in sentinel lymph node-positive melanoma patients.

Murali R, Desilva C, Thompson JF, Scolyer RA.

Ann Surg. 2011 Jun;253(6):1155-64. doi: 10.1097/SLA.0b013e318214beba.

PMID:
21412144

Supplemental Content

Support Center